{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T01:15:10Z","timestamp":1726276510876},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2011,2,8]],"date-time":"2011-02-08T00:00:00Z","timestamp":1297123200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s10620-011-1583-4","type":"journal-article","created":{"date-parts":[[2011,2,7]],"date-time":"2011-02-07T04:21:53Z","timestamp":1297052513000},"page":"2333-2342","source":"Crossref","is-referenced-by-count":3,"title":["Acid-Suppressive Effect of Rabeprazole 5\u00a0mg and 10\u00a0mg Once Daily by 24-Hour Esophageal pH Monitoring in Patients with Non-erosive Reflux Disease in Japan: A Multicenter, Randomized, Parallel-Group, Double-Blind Pharmacodynamic Study"],"prefix":"10.1007","volume":"56","author":[{"name":"The Japan Rabeprazole Study Group for NERD","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Ashida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Hongo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,2,8]]},"reference":[{"key":"1583_CR1","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","volume":"101","author":"N Vakil","year":"2006","unstructured":"Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900\u20131920.","journal-title":"Am J Gastroenterol"},{"key":"1583_CR2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.mcg.0000225631.07039.6d","volume":"41","author":"R Fass","year":"2007","unstructured":"Fass R. Erosive Esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics. J Clin Gastroenterol. 2007;41:131\u2013137.","journal-title":"J Clin Gastroenterol"},{"key":"1583_CR3","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0002-9270(03)00009-1","volume":"98","author":"R Fass","year":"2003","unstructured":"Fass R. Epidemiology and pathophysiology of symptomatic gastroesophageal reflux disease. Am J Gastroenterol. 2003;98:S2\u2013S7.","journal-title":"Am J Gastroenterol"},{"key":"1583_CR4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2036.2005.02608.x","volume":"22","author":"EM Quigley","year":"2005","unstructured":"Quigley EM, Hungin AP. Review article: quality of life issues in gastro-oesophageal reflux diseases. Aliment Pharmacol Ther. 2005;22:41\u201347.","journal-title":"Aliment Pharmacol Ther"},{"key":"1583_CR5","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1023\/B:DDAS.0000007857.15694.15","volume":"48","author":"K Okamoto","year":"2003","unstructured":"Okamoto K, Iwakiri R, Mori M, et al. Clinical symptoms in endoscopic reflux esophagitis: evaluation in 8031 adult subjects. Dig Dis Sci. 2003;48:2237\u20132241.","journal-title":"Dig Dis Sci"},{"key":"1583_CR6","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1080\/00365520510023260","volume":"40","author":"I Mishima","year":"2005","unstructured":"Mishima I, Adachi K, Arima N, et al. Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese. Scand J Gastroenterol. 2005;40:1005\u20131009.","journal-title":"Scand J Gastroenterol"},{"key":"1583_CR7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/00003495-200666991-00004","volume":"66","author":"JP Galmiche","year":"2006","unstructured":"Galmiche JP. Non-erosive reflux disease and atypical gastro-oesophageal reflux disease manifestations: treatment results. Drugs. 2006;66:7\u201313.","journal-title":"Drugs"},{"key":"1583_CR8","first-page":"CD002095","volume":"4","author":"B Pinxteren van","year":"2004","unstructured":"van Pinxteren B, Numans ME, Bonis PA, et al. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev. 2004;4:CD002095.","journal-title":"Cochrane Database Syst Rev"},{"key":"1583_CR9","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.3748\/wjg.v11.i20.3091","volume":"11","author":"KM Fock","year":"2005","unstructured":"Fock KM, Teo EK, Ang TL, et al. Rabeprazole vs. esomeprazole in non-erosive gastroesophageal reflux disease: a randomized, double-blind study in urban Asia. World J Gastroenterol. 2005;11:3091\u20133098.","journal-title":"World J Gastroenterol"},{"key":"1583_CR10","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1046\/j.1440-1746.2003.03190.x","volume":"18","author":"K Adachi","year":"2003","unstructured":"Adachi K, Hashimoto T, Hamamoto N, et al. Symptom relief in patients with reflux esophagitis: comparative study of omeprazole, lansoprazole, and rabeprazole. J Gastroenterol Hepatol. 2003;18:1392\u20131398.","journal-title":"J Gastroenterol Hepatol"},{"key":"1583_CR11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1365-2036.2002.01181.x","volume":"16","author":"M Robinson","year":"2002","unstructured":"Robinson M, Fitzgerald S, Hegedus R, et al. Onset of symptom relief with rabeprazole: a community-based, open-label assessment of patients with erosive oesophagitis. Aliment Pharmacol Ther. 2002;16:445\u2013454.","journal-title":"Aliment Pharmacol Ther"},{"key":"1583_CR12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.1365-2036.2002.01207.x","volume":"16","author":"G Holtmann","year":"2002","unstructured":"Holtmann G, Bytzer P, Metz M, et al. A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2002;16:479\u2013485.","journal-title":"Aliment Pharmacol Ther"},{"key":"1583_CR13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2036.2004.02162.x","volume":"20","author":"P Miner","year":"2004","unstructured":"Miner P. Relief of symptoms in gastric acid-related diseases-correlation with acid suppression in rabeprazole treatment. Aliment Pharmacol Ther. 2004;20:20\u201329.","journal-title":"Aliment Pharmacol Ther"},{"key":"1583_CR14","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1572-0241.2002.05769.x","volume":"97","author":"P Miner Jr","year":"2002","unstructured":"Miner P Jr, Orr W, Filippone J, et al. Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial. Am J Gastroenterol. 2002;97:1332\u20131339.","journal-title":"Am J Gastroenterol"},{"key":"1583_CR15","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1053\/gast.1996.1101982","volume":"110","author":"PJ Kahrilas","year":"1996","unstructured":"Kahrilas PJ, Quigley EM. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterol. 1996;110:1982\u20131996.","journal-title":"Gastroenterol"},{"key":"1583_CR16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2036.2006.02801.x","volume":"23","author":"PO Katz","year":"2006","unstructured":"Katz PO. Review article: intragastric and oesophageal pH monitoring in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2006;23:3\u201311.","journal-title":"Aliment Pharmacol Ther"},{"key":"1583_CR17","first-page":"1459","volume":"62","author":"Y Hoshihara","year":"2004","unstructured":"Hoshihara Y. Endoscopic findings of GERD. Nippon Rinsho. 2004;62:1459\u20131464.","journal-title":"Nippon Rinsho"},{"key":"1583_CR18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00535-006-1775-4","volume":"41","author":"M Hongo","year":"2006","unstructured":"Hongo M. Minimal changes in reflux esophagitis: red ones and white ones. J Gastroenterol. 2006;41:95\u201399.","journal-title":"J Gastroenterol"},{"key":"1583_CR19","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00535-007-2022-3","volume":"42","author":"T Joh","year":"2007","unstructured":"Joh T, Miwa H, Higuchi K, et al. Validity of endoscopic classification of nonerosive reflux disease. J Gastroenterol. 2007;42:444\u2013449.","journal-title":"J Gastroenterol"},{"key":"1583_CR20","first-page":"358","volume":"83","author":"GJ Wiener","year":"1988","unstructured":"Wiener GJ, Richter JE, Copper JB, et al. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol. 1988;83:358\u2013361.","journal-title":"Am J Gastroenterol"},{"key":"1583_CR21","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/bjs.1800791022","volume":"79","author":"BT Johnston","year":"1992","unstructured":"Johnston BT, McFarland RJ, Collins JS, et al. Symptom index as a marker of gastro-oesophageal reflux disease. Br J Surg. 1992;79:1054\u20131055.","journal-title":"Br J Surg"},{"key":"1583_CR22","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S0002-9270(03)00011-X","volume":"98","author":"PJ Kahrilas","year":"2003","unstructured":"Kahrilas PJ. Diagnosis of symptomatic gastroesophageal reflux disease. Am J Gastroenterol. 2003;98:S15\u2013S23.","journal-title":"Am J Gastroenterol"},{"key":"1583_CR23","first-page":"1893","volume":"88","author":"P Kasapidis","year":"1993","unstructured":"Kasapidis P, Xynos E, Mantides A, et al. Differences in manometry and 24-H ambulatory pH-metry between patients with and without endoscopic or histological esophagitis in gastroesophageal reflux disease. Am J Gastroenterol. 1993;88:1893\u20131899.","journal-title":"Am J Gastroenterol"},{"key":"1583_CR24","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1053\/gast.1996.v111.pm8898632","volume":"111","author":"MF Vaezi","year":"1996","unstructured":"Vaezi MF, Richter JE. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology. 1996;111:1192\u20131199.","journal-title":"Gastroenterology"},{"key":"1583_CR25","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1046\/j.1365-2036.2003.01423.x","volume":"17","author":"SD Martinez","year":"2003","unstructured":"Martinez SD, Malagon IB, Garewal HS, et al. Non-erosive reflux disease (NERD) -acid reflux and symptom patterns. Aliment Pharmacol Ther. 2003;17:537\u2013545.","journal-title":"Aliment Pharmacol Ther"},{"key":"1583_CR26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2036.2004.01990.x","volume":"20","author":"H Miwa","year":"2004","unstructured":"Miwa H, Minoo T, Hojo M, et al. Oesophageal hypersensitivity in Japanese patients with non-erosive gastro-oesophageal reflux diseases. Aliment Pharmacol Ther. 2004;20:112\u2013117.","journal-title":"Aliment Pharmacol Ther"},{"key":"1583_CR27","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3109\/00365529709011212","volume":"32","author":"T Lind","year":"1997","unstructured":"Lind T, Havelund T, Carlsson R, et al. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol. 1997;32:974\u2013979.","journal-title":"Scand J Gastroenterol"},{"key":"1583_CR28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2036.2007.03350.x","volume":"26","author":"H Miwa","year":"2007","unstructured":"Miwa H, Sasaki M, Furuta T, et al. Efficacy of proton pump inhibitor, rabeprazole, on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from Japan. Aliment Pharmacol Ther. 2007;26:69\u201377.","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-011-1583-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-011-1583-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-011-1583-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T15:44:47Z","timestamp":1559231087000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-011-1583-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,8]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["1583"],"URL":"https:\/\/doi.org\/10.1007\/s10620-011-1583-4","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2011,2,8]]}}}